Johanna Hynninen
Adjunct professor, MD, Gynecologic oncologist
mijohy@utu.fi ORCID identifier: https://orcid.org/0000-0002-0854-7225 |
Areas of expertise
gynaecologic oncology; ovarian cancer
gynaecologic oncology; ovarian cancer
Research community or research topic
https://sites.utu.fi/ovariancancer/ https://www.deciderproject.eu
https://sites.utu.fi/ovariancancer/ https://www.deciderproject.eu
Publications
- Network-guided identification of cancer-selective combinatorial therapies in ovarian cancerPRISM: Recovering cell type specific expression profiles from individual composite RNA-seq samples (2021)
- Briefings in BioinformaticsBioinformatics
(A1 Refereed original research article in a scientific journal) - (2021)
(A1 Refereed original research article in a scientific journal) - Syöpäsolujen lääkeresistenssi ja miten se voitetaan - valokeilassa munasarjasyöpäALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors (2021)
- Duodecim
- (2020)
- Journal of Pathology
(A1 Refereed original research article in a scientific journal) - A longitudinal analysis of CA125 glycoforms in the monitoring and follow up of high grade serous ovarian cancer (2020)
- Gynecologic Oncology
(A1 Refereed original research article in a scientific journal) - American Association for Cancer Research Special Conference on Advances in Ovarian Cancer Research Sep 13-16, 2019 Atlanta, GA, USA Abstracts (2020)
- Clinical Cancer Research
(Other publication) - Analysis of single-cell RNA-seq data from ovarian cancer samples before and after chemotherapy links stress-related transcriptional profile with chemotherapy resistance (2020)
- bioRxiv
(Other publication) - Author Correction: Virtual clinical trials identify effective combination therapies in ovarian cancer (2020)
- Scientific Reports
(Other publication) - Exploratory Analysis of CA125-MGL and –STn Glycoforms in the Differential Diagnostics of Pelvic Masses (2020)
- The Journal of Applied Laboratory Medicine
(A1 Refereed original research article in a scientific journal) - Extracellular matrix proteins increase invasive growth and chemotherapy resistance of ovarian cancer cellsGlycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125 (2020)
- Clinical Cancer ResearchCommunications Biology
(Other publication) - (2020)
(A1 Refereed original research article in a scientific journal) - HE4 in the evaluation of tumor load and prognostic stratification of high grade serous ovarian carcinoma (2020)
- Acta Oncologica
(A1 Refereed original research article in a scientific journal) - (2020)
- Bioinformatics
(A1 Refereed original research article in a scientific journal) - (2020)
- Clinical Cancer Research
(Other publication) - (2020)
- Clinical Cancer ResearchCancer Imaging
(Other publication) - (2020)
- EJNMMI ResearchClinical Cancer Research
(A1 Refereed original research article in a scientific journal) - Behavior of FDG-avid supradiaphragmatic lymph nodes in PET/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study (2019)
(A1 Refereed original research article in a scientific journal) - CtDNA profiling to predict prognosis and optimize treatment in high-grade serous ovarian cancer (2019)
(Other publication) - Europium Nanoparticle-Based Sialyl-Tn Monoclonal Antibody Discriminates Epithelial Ovarian Cancer-Associated CA125 from Benign Sources (2019)
- The Journal of Applied Laboratory Medicine
(A1 Refereed original research article in a scientific journal) - Open Source Infrastructure for Health Care Data Integration and Machine Learning Analyses (2019)
- JCO Clinical Cancer Informatics
(A1 Refereed original research article in a scientific journal)